Related Experiment Video
Updated: Jun 12, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Nebuliser therapy in critical care: The past, present and future
Andrew Arnott1, Malcolm Watson1, Malcolm Sim1
1Queen Elizabeth University Hospital, Glasgow, UK.
Vibrating mesh nebulisers (VMN) offer improved drug delivery for critical illnesses compared to older jet (JN) and ultrasonic (USN) devices. This review covers nebuliser evolution, science, and critical care applications.
Area of Science:
- Pulmonary Medicine
- Biomedical Engineering
- Pharmacology
Background:
- Nebulisers convert liquids into inhalable aerosols for drug delivery.
- Pulmonary drug absorption offers efficient local and systemic treatment, especially in critical care.
- Conventional jet (JN) and ultrasonic nebulisers (USN) have limitations in efficiency and particle size.
Purpose of the Study:
- To review the historical development of nebuliser technology.
- To explain the basic science of nebulisation and pulmonary drug delivery.
- To discuss the current applications of nebulised therapies in critical care settings.
Main Methods:
- Literature review of nebuliser technology evolution.
- Analysis of the scientific principles behind nebulisation and aerosol deposition.
- Examination of clinical data on nebulised therapies in critical illness.
Main Results:
- Vibrating mesh nebulisers (VMN) represent a significant advancement over JN and USN.
- VMN technology enhances aerosol generation efficiency and therapeutic potential.
- Nebulised therapies are crucial for managing critical illnesses.
Conclusions:
- VMN have revolutionized nebuliser therapy, offering superior drug delivery.
- Understanding nebuliser science is key to optimizing critical care treatments.
- This review provides a comprehensive overview of nebulisers in critical care.
More Related Videos
Related Concept Videos
Inhaled Medications
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

